CD8A and cancer: On theoretical grounds, the endogenous T cell compartments, especially CD8+ T cells, are capable of recognizing peptide epitopes derived from specific mutations in tumor or viral open reading frames, which are displayed on major histocompatibility complexes (MHCs) on the surface of the malignant tumor cells (82).